Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Leonard

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|April 12, 2019
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recoveryAlexis Leonard, Aylin Bonifacino, Venina M Dominical, et al.
Cytotherapy|December 9, 2021
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantationAlexis Leonard, Alice Bertaina, Carmem Bonfim, et al.
Annals of the American Thoracic Society|August 27, 2024
Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell DiseaseA Parker Ruhl, Ruba Shalhoub, Neal Jeffries, et al.
Molecular Therapy. Methods & Clinical Development|February 22, 2019
High-Efficiency Lentiviral Transduction of Human CD34<sup>+</sup> Cells in High-Density Culture with Poloxamer and Prostaglandin E2Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Molecular Therapy. Methods & Clinical Development|January 1, 2020
Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient MiceAlexis Leonard, Morgan Yapundich, Tina Nassehi, et al.
Stem Cell Research & Therapy|November 25, 2020
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiationSelami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Frontiers in Medicine|March 6, 2023
Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospitalOlufunke Y Martin, Deepika S Darbari, Stefanie Margulies, et al.
American Journal of Medical Genetics. Part A|October 21, 2025
Growth Standards for Children With Smith-Magenis Syndrome (SMS)Julie Hoover-Fong, John McGready, Leah Fleming, et al.
British Journal of Haematology|June 23, 2022
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell diseaseAkshay Sharma, Alexis Leonard, Kamille West, et al.
Blood Advances|May 6, 2021
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell diseaseAlexis Leonard, Akshay Sharma, Naoya Uchida, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|April 12, 2019
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recoveryAlexis Leonard, Aylin Bonifacino, Venina M Dominical, et al.
Cytotherapy|December 9, 2021
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantationAlexis Leonard, Alice Bertaina, Carmem Bonfim, et al.
Annals of the American Thoracic Society|August 27, 2024
Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell DiseaseA Parker Ruhl, Ruba Shalhoub, Neal Jeffries, et al.
Molecular Therapy. Methods & Clinical Development|February 22, 2019
High-Efficiency Lentiviral Transduction of Human CD34<sup>+</sup> Cells in High-Density Culture with Poloxamer and Prostaglandin E2Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Molecular Therapy. Methods & Clinical Development|January 1, 2020
Low-Dose Busulfan Reduces Human CD34<sup>+</sup> Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient MiceAlexis Leonard, Morgan Yapundich, Tina Nassehi, et al.
Stem Cell Research & Therapy|November 25, 2020
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiationSelami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Frontiers in Medicine|March 6, 2023
Clinical outcomes of children and adolescents with sickle cell disease and COVID-19 infection: A year in review at a metropolitan tertiary pediatric hospitalOlufunke Y Martin, Deepika S Darbari, Stefanie Margulies, et al.
American Journal of Medical Genetics. Part A|October 21, 2025
Growth Standards for Children With Smith-Magenis Syndrome (SMS)Julie Hoover-Fong, John McGready, Leah Fleming, et al.
British Journal of Haematology|June 23, 2022
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell diseaseAkshay Sharma, Alexis Leonard, Kamille West, et al.
Blood Advances|May 6, 2021
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell diseaseAlexis Leonard, Akshay Sharma, Naoya Uchida, et al.
Pageof 4